Is QXO (QXO) Undervalued On The Utah Verdict Despite No Negligence Finding?

QXO, Inc.

QXO, Inc.

QXO

0.00

A Utah jury’s $86 million nuclear verdict against QXO (QXO), despite no finding of negligence, has put the company’s legal exposure in sharp focus for investors watching litigation risks across the freight sector.

The Utah verdict landed after a weak stretch for QXO, with the share price falling 22.2% year to date and the 1 year total shareholder return declining 21%. Yet the 1 day share price return of 8.9% and 7 day gain of 7.6% suggest traders are reassessing the legal risk in light of the jury’s finding of no negligence.

If this legal shock has you rethinking your exposure to freight and construction, it can be useful to scan other parts of the market through the lens of 19 top founder-led companies

After a sharp slide over 1 year and an abrupt bounce on the verdict news, QXO now sits at a market value of about US$14.6b and a share price of US$15.34. Investors may now be considering whether that mix of legal overhang and apparent discount still rewards buyers, or whether the current price instead reflects too much optimism in the valuation.

Most Popular Narrative: 52.8% Undervalued

The most followed narrative on QXO values the stock at $32.53 per share, which sits well above the last close at $15.34 and frames a large valuation gap that some investors are watching closely.

QXO represents a disciplined M&A consolidation play in the $800B building products distribution market, led by Brad Jacobs, the most proven serial acquirer in modern industrial history (300x cumulative returns across four prior platforms, ~500 acquisitions). The company has built a $2.13B EBITDA pro-forma platform in under 18 months by acquiring Beacon Roofing Supply ($11B), Kodiak Building Partners ($2.25B), and TopBuild ($17B, closed July 1), creating the largest publicly traded building products distributor in North America with #1 positions in insulation and waterproofing and #2 in roofing.

The core of this QXO narrative is a roll up aiming to scale revenue sharply, expand margins through technology and procurement, and support that fair value with a richer earnings profile than the current losses suggest.

Result: Fair Value of $32.53 (UNDERVALUED)

However, QXO’s narrative still hinges on complex preferred stock and debt structures, and any stumble in integrating large acquisitions could quickly challenge that optimism.

Another View on QXO’s Valuation

The user narrative leans on long term revenue and margin targets to argue QXO is undervalued around a fair value of $32.53 per share. Yet on today’s numbers QXO trades on a P/S of 1.9x, which screens as expensive against both peers at 1.6x and the wider US Trade Distributors group at 1.2x.

At the same time, the fair ratio for QXO’s P/S is 5.4x. That is a large gap between what the market currently pays, what peers trade on, and where the fair ratio suggests the multiple could move. For investors weighing that spread, this may either be an opening or a sign the story still needs to be proven.

NYSE:QXO P/S Ratio as at Aug 2026
NYSE:QXO P/S Ratio as at Aug 2026

Next Steps

If this mix of optimism and concern around QXO leaves you unsure, take a fresh look at the numbers, recent news, and the 2 key rewards and 1 important warning sign

Looking for more investment ideas beyond QXO?

If QXO has sharpened your focus on risk and reward, it is worth lining up a few fresh ideas using targeted stock lists that highlight different strengths.

  • Spot potential upside in companies that may be priced below their fundamentals with the help of the 52 high quality undervalued stocks.
  • Prioritise resilience by scanning companies that score well on stability and risk using the 82 resilient stocks with low risk scores.
  • Hunt for underfollowed opportunities that still show solid quality markers by checking the screener containing 18 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.